StockNews.com Initiates Coverage on Cutera (NASDAQ:CUTR)

StockNews.com assumed coverage on shares of Cutera (NASDAQ:CUTR) in a research note issued on Thursday. The brokerage set a “sell” rating on the medical device company’s stock.

Cutera Stock Down 63.9 %

Shares of NASDAQ:CUTR opened at $0.04 on Thursday. The firm has a market cap of $787,254.00, a P/E ratio of -0.01 and a beta of 1.36. Cutera has a 12-month low of $0.09 and a 12-month high of $3.00. The business has a fifty day simple moving average of $0.27 and a 200 day simple moving average of $0.43.

Hedge Funds Weigh In On Cutera

An institutional investor recently bought a new position in Cutera stock. Sculptor Capital LP purchased a new position in shares of Cutera, Inc. (NASDAQ:CUTR) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned about 0.82% of Cutera as of its most recent filing with the SEC. 90.70% of the stock is currently owned by institutional investors.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.